![Robert Michael](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Michael
Chief Executive Officer at
ABBVIE INC.
Net worth: 38 M $ as of 30/04/2026
Profile
Robert A. Michael is Chief Financial Officer & Executive Vice President for AbbVie, Inc. and Chief Executive Officer at Fremont Holding LLC, Chief Executive Officer at Tobira Therapeutics, Inc. and President & Director at Allergan Plc (which are all subsidiaries of AbbVie, Inc.). Mr. Michael is also on the board of AbbVie Biotherapeutics Ltd. Mr. Michael previously held the position of Division Controller-Nutrition Supply Chain at Abbott Laboratories. He received an MBA from Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ABBVIE, INC. 0.01% | 06/03/2026 | 178,737 ( 0.01% ) | 38 M $ | 30/04/2026 |
Latest news about Robert Michael
Robert Michael active positions
| Companies | Position | Start |
|---|---|---|
| ABBVIE INC. | Chief Executive Officer | 01/07/2024 |
| ALLERGAN PLC | President | 08/05/2020 |
| TOBIRA THERAPEUTICS INC | Chief Executive Officer | - |
AbbVie Biotherapeutics Ltd.
 AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 01/04/2019 |
Fremont Holding LLC
 Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Chief Executive Officer | - |
AbbVie Ltd. (United Kingdom)
 AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | President | 01/01/2022 |
Former positions of Robert Michael
| Companies | Position | End |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/2012 |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | President | - |
Training of Robert Michael
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases | Health Technology |
Fremont Holding LLC
Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
AbbVie Ltd. (United Kingdom)
AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Develops advanced therapies through research and innovation | Commercial Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
AbbVie Biotherapeutics Ltd.
AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Robert Michael
